---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-067535"
form_type: "8-K"
ticker: "SXTP"
cik: "0001946563"
company_name: "60 DEGREES PHARMACEUTICALS, INC."
filed_at: "2024-08-12T23:59:59+00:00"
generated_at: "2026-05-31T10:10:26.185630+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# 60 Degrees Pharmaceuticals effects 1:12 reverse stock split to regain Nasdaq compliance

## Summary
- Reverse stock split at 1-for-12 ratio effective August 12, 2024; new CUSIP 83006G203.
- Split aims to bring stock price above Nasdaq's $1.00 minimum bid requirement.
- Stockholders approved reverse split range on July 16; Board set exact ratio on July 19.
- No fractional shares issued; all fractional amounts rounded up to one whole share.
- Common stock symbol SXTP unchanged; warrants symbol SXTPW unchanged.

## SEC filing metadata
- accession: 0001213900-24-067535
- form_type: 8-K
- ticker: SXTP
- cik: 0001946563
- company_name: 60 DEGREES PHARMACEUTICALS, INC.
- filed_at: 2024-08-12T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1946563/000121390024067535/0001213900-24-067535-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1946563/000121390024067535/ea0211125-8k_60degrees.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-067535
- JSON: https://secwatch.observer/filing/0001213900-24-067535.json
- Plain text: https://secwatch.observer/filing/0001213900-24-067535.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.